The ERCC4 gene gives your cells instructions for a DNA repair protein called XPF, which helps fix damage caused by sunlight and other everyday stresses. This gene helps your body maintain healthy DNA, especially in skin cells and other cells that divide often. If the ERCC4 gene does not work properly, DNA damage can build up over time. Depending on the variant, this may lead to marked sun sensitivity, a higher chance of skin cancer, growth and development problems, or reduced bone marrow function.
What is a gene?
Genes are sections of DNA that carry instructions cells use to make molecules or manage processes in the body. Some hold the directions for producing proteins, the parts of cells that do the work. Others are mainly involved in controlling when certain processes happen, where they occur, and how strongly they operate. In combination, genes affect how the body develops and functions, and they can also shape how you respond to food, stress, or medications. For a closer look at this topic, more information is available in the LearnHub.
Overview
ERCC4Gene function
What if the gene works
The ERCC4 gene helps cells repair damaged DNA. Its protein cuts out damaged DNA sections, especially after UV light or certain chemical damage. This helps keep cells working normally.
Risk
What if the gene does not work
Variants in the ERCC4 gene can impair DNA repair. More severe variants may cause xeroderma pigmentosum with marked sun sensitivity and higher skin cancer risk, while others can lead to Fanconi anemia or related childhood growth and bone marrow problems.
Treatment
What does that mean for your treatment
No ERCC4-specific treatment or drug selection approach is currently established in clinical guidelines. In research, changes in the ERCC4 gene are being studied as possible markers of how some cancers respond to DNA-damaging treatments such as platinum chemotherapy, but this is not yet standard care.
Conditions associated with ERCC4
Gene function
What if the gene works
Every day, sunlight, normal metabolism, and routine cell activity can nick or distort DNA. The ERCC4 gene helps your cells clear this damage so important instructions stay readable. Its protein acts like a precise DNA cutting tool in repair systems that keep cell activity steady over time.
Its protein joins with ERCC1 to cut DNA at carefully chosen spots during repair. This lets the cell remove a damaged section and replace it with a clean stretch.
One of its main jobs is helping remove larger DNA damage, including damage caused by UV light from the sun. This is a key part of how the ERCC4 gene helps repair DNA and keeps genetic instructions readable.
Some chemicals can glue the two strands of DNA together, creating a block called a crosslink. ERCC4 helps open and trim these blocked areas so other repair proteins can finish the cleanup.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many ERCC4 gene variants change the XPF protein’s shape, stability, or ability to bind ERCC1 and cut damaged DNA, which helps explain how ERCC4 gene variants affect DNA repair. Milder variants may leave some cutting activity in place, while more severe variants can sharply reduce it or stop it. Some changes also weaken contact with repair partners such as SLX4. In ERCC4-related conditions, lower remaining activity often links to earlier onset and a broader or more noticeable mix of features.
How variants are linked to conditions
Pathogenic variants in the ERCC4 gene can cause xeroderma pigmentosum group F, a condition marked by extreme sun sensitivity and a much higher risk of skin cancers. Some people with ERCC4 variants have Fanconi anemia type Q, which may involve bone marrow problems, growth differences, and birth differences. Inherited ERCC4 gene variants linked to conditions are rare, and the specific health effects depend on which variant a person carries.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widespread in the general population. Most do not directly affect health and instead reflect normal human variation. For many genes, having a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental influences are involved. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For people with harmful changes in the ERCC4 gene, risk is driven mainly by the gene change itself, but ultraviolet light from the sun or tanning beds can greatly raise the chance of skin damage and skin cancer in those with related sun-sensitive conditions. Careful sun protection and regular skin checks help lower complications through early detection.
Inheritance of ERCC4 variants
ERCC4-related conditions are inherited in an autosomal recessive pattern. This means a person usually develops an ERCC4-related condition only when they inherit two disease-causing variants in the ERCC4 gene, one from each parent. Parents who each carry one variant are often called carriers and, with each pregnancy, have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with neither variant. In families asking how ERCC4 variants are inherited, this pattern applies to the well-established conditions linked to this gene.
What does my ERCC4 result mean for my family?
For well-known ERCC4-related conditions, the family pattern is usually recessive, which means parents are often healthy carriers of one changed copy. Brothers and sisters may also be carriers, and some may have the condition if they inherited two changed copies. Children of someone with an ERCC4-related condition will usually be carriers unless the other parent also carries an ERCC4 change.
Genetic information
Genetic testing
How you find out about variants
ERCC4 genetic testing looks for variants in the ERCC4 gene using a blood sample, saliva, or a cheek swab. Labs read the gene’s DNA sequence to see whether a variant is present and classify it as benign, uncertain, or linked to a condition. Results can confirm or help clarify a suspected inherited condition.
When should I consider getting a genetic test?
Consider ERCC4 testing if someone has extreme sun sensitivity, unusual freckling, or repeated skin cancers at a young age, or if these problems run in the family. It may also help when doctors are looking for a rare inherited condition linked to poor DNA repair, including some forms of bone marrow failure.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how informative they are varies with the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also shape how the body functions. For some conditions, particularly those influenced by many genes, genetic information offers context rather than certainty and is best understood alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, these results can also help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it into tissues, or responds to its effects. This helps explain why the same treatment may work well for one person, seem less effective for another, or cause more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect the way someone responds to medicines. It looks at connections between genes and drugs to better explain why the same treatment may work differently from one person to another. For many medications, genes can influence both how strongly a drug works and how the body handles it. This information can help support more informed, more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the ERCC4 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding routine medication choices, so general questions about side effects, new symptoms, or how a treatment is working are best discussed with your doctor. ERCC4 has been studied in cancer research for possible links to response to some DNA-damaging chemotherapy medicines, but this has not become standard care.
History
ERCC4 entered medical genetics through research on rare inherited conditions in which the body has trouble repairing DNA damage. In the late 20th century, scientists studying xeroderma pigmentosum identified one form, called complementation group F, and later traced it to changes in the ERCC4 gene. Building on this early work, scientists uncovered more about the gene as part of a repair partnership known as XPF-ERCC1. That discovery helped connect ERCC4 to several related conditions, including some cases of Cockayne syndrome and Fanconi anemia. Over time, descriptions became more precise as laboratory methods improved and researchers could match specific gene variants to different clinical patterns. Today, ERCC4 is recognized as an important part of the broader history of DNA repair research.